| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | — | -48.4% |
| Cost of Revenue | $1.3M | — | -63.3% |
| Gross Profit | $1.8M | — | -26.7% |
| R&D Expense | $2.0M | — | +118.0% |
| SG&A Expense | $4.1M | — | +5.7% |
| Operating Income | -$6.3M | — | +19.9% |
| Pre-tax Income | -$7.8M | — | -99.3% |
| Income Tax | $70K | — | +775.0% |
| Net Income | -$7.5M | — | -89.9% |
| EPS (Basic) | -$0.17 | — | -70.0% |
| EPS (Diluted) | -$0.17 | — | +19.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.5M | -21.6% | +64.1% |
| Accounts Receivable | $2.1M | +19.3% | -27.7% |
| Inventory | $2.7M | +1.5% | -38.0% |
| Current Assets | $48.6M | -12.9% | +61.9% |
| Total Assets | $55.2M | -11.5% | +40.5% |
| Current Liabilities | $23.7M | -5.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.8M | — | +11.8% |
| Capital Expenditures | $459K | — | +65.1% |
| Investing Cash Flow | -$34K | — | +87.8% |
| Financing Cash Flow | $3K | — | -100.0% |
| Free Cash Flow | -$8.3M | — | +9.5% |
| -35.6% |
| Total Liabilities | $32.7M | -5.8% | -56.9% |
| Stockholders' Equity | $22.5M | -18.6% | +161.8% |